BLOG / 🇺🇸 United States · · daily

VA Healthcare & Services Contracts — July 08, 2026

VA Healthcare & Services Contracts

By Gunpowder Editorial ·

1 total filings analysed

Executive Summary

The single contract digest for July 8, 2026, covers a $81.3 million modification awarded to TISTA SCIENCE AND TECHNOLOGY CORPORATION by the Department of Veterans Affairs, representing a purely civilian healthcare and services stream with no defense exposure.

The contract carries a neutral signal with medium confidence, as key details on pricing, competition, and revenue impact are unknown, limiting actionable conviction. The dominant theme is VA healthcare IT or services spending, but the lack of competitive context or performance risk data makes this a watch-and-confirm item rather than a clear catalyst. Key risk is the absence of transparency on whether this is a sole-source or competed award, which could imply either a strong incumbent position or a protest-vulnerable non-competitive award.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Tracking the trend? Catch up on the prior VA Healthcare & Services Contracts digest from June 27, 2026.

Investment Signals (1)

  • TISTA SCIENCE AND TECHNOLOGY CORPORATION Secures $81.3M VA Contract Modification (MEDIUM)

    TISTA received a contract modification from the Department of Veterans Affairs valued at $81.3 million, but with unknown pricing structure, competition dynamics, and revenue impact, the signal is neutral. The lack of defense alignment reduces strategic urgency for defense-focused investors.

Risk Flags (2)

  • Execution [MEDIUM RISK]

    The contract modification for TISTA has unknown pricing (fixed-price vs. cost-plus) and unknown competition signal, creating execution risk if the award is a non-competitive sole-source that could face protest or if it is a fixed-price contract with thin margins.

  • Concentration [MEDIUM RISK]

    With only one contract in this digest, there is no diversification across agencies or recipients, but the $81.3 million single-award concentration to TISTA represents a material dependency for the company if it is a small or mid-tier contractor.

Opportunities (1)

  • The VA's continued spending on healthcare services and IT through modifications like this $81.3M award signals sustained demand for civilian agency support, potentially benefiting contractors with VA relationships such as TISTA, Leidos, or Cerner (Oracle Health).

Sector Themes (1)

  • The $81.3 million modification to TISTA underscores ongoing VA investment in healthcare support services, even as broader federal budgets face Continuing Resolution uncertainty. This theme is supported by the single contract award, which is purely civilian and not tied to defense priorities.

Watch List (2)

  • 👁

    {"entity"=>"TISTA SCIENCE AND TECHNOLOGY CORPORATION", "reason"=>"The $81.3M VA contract modification is a material award for a company with unknown annual revenue, making it a potential growth story if the company is small-cap and this represents a significant revenue boost.", "trigger"=>"Disclosure of contract details (pricing type, competition status) or TISTA's financial filings showing revenue impact"}

  • 👁

    {"entity"=>"Department of Veterans Affairs", "reason"=>"VA is the sole agency in this digest, and its procurement patterns for healthcare services are critical for civilian contractors. A shift toward more competitive or set-aside awards could change the landscape.", "trigger"=>"VA budget request for FY2027, NDAA provisions affecting veteran healthcare, or new RFPs for similar services"}

Get daily alerts with 1 investment signals, 2 risk alerts, 1 opportunities and full AI analysis of all 1 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: VA Healthcare & Services Contracts

🇺🇸 More from United States

View all →